Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
7. Johnson & Johnson’s Q2 earnings soar 172%
Second-quarter earnings for Johnson & Johnson soared more than 172%, but its medical device & diagnostics division disappoints.
6. Medical device tax payments hit the $1B mark
Medtech companies have collectively paid an estimated $1 billion in compliance with the Affordable Care Act’s 2.3% medical device sales tax.
5. Edwards Lifesciences goes after another set of Medtronic patents
Edwards Lifesciences wants a federal judge to invalidate a pair of patents covering nerve stimulation sensing technology owned by arch-rival Medtronic.
4. Abbott acquires IDEV Technologies, OptiMedica
Abbott agrees to pay $310 million for peripheral stent maker IDEV Technologies and up to $400 million for OptiMedica, which makes laser cataract surgery devices.
3. Medtronic’s insulin pump recall gets FDA’s highest-risk label
U.S. healthcare regulators put their highest-risk Class I label on Medtronic’s Paradigm insulin infusion pump recall.
2. Medtronic recalls implantable pacemakers over manufacturing concerns
Minnesota medical device titan Medtronic recalls certain lots of its Consulta and Syncra CRT-P implants after discovering a manufacturing issue that could "compromise device functionality."
1. FDA issues Class II recall on Intuitive Surgical’s da Vinci surgical robot
Thirty of Intuitive Surgical’s da Vinci surgical robots might not have been properly tested, according to the FDA, which issues a Class II recall on some models and components of the device.
